Get started
Author

P. Brunetti

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
2000 · M Lepore, S Pampanelli, et al. · Diabetes · 813
PDF
Efficacy and Safety of Pioglitazone Versus Metformin in Patients with Type 2 Diabetes Mellitus: A Double-Blind, Randomized Trial
2004 · G. Schernthaner, D. R. Matthews, et al. · The Journal of Clinical Endocrinology & Metabolism · 267
Reversibility of Unawareness of Hypoglycemia in Patients with Insulinomas
1993 · A. Mitrakou, C. Fanelli, et al. · New England Journal of Medicine · 219
PDF
Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM
1994 · C. Fanelli, S. Pampanelli, et al. · Diabetologia · 212
PDF
Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.
1999 · C Lalli, M Ciofetta, et al. · Diabetes Care · 192
Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans
1994 · C. Fanelli, S. Pampanelli, et al. · Diabetologia · 192
PDF
Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study
2004 · D. R. Matthews, B. H. Charbonnel, et al. · Diabetes/Metabolism Research and Reviews · 174
Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes
2005 · B. Charbonnel, G. Schernthaner, et al. · Diabetologia · 170
PDF
High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase
1995 · A Falorni, A Nikoshkov, et al. · The Journal of Clinical Endocrinology & Metabolism · 159
Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans.
1993 · C Fanelli, S Calderone, et al. · Journal of Clinical Investigation · 159
PDF
A long‐term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double‐blind, parallel‐group comparison trial
2005 · B. H. Charbonnel, D. R. Matthews, et al. · Diabetic Medicine · 143
Contribution of cortisol to glucose counterregulation in humans
1989 · P. De Feo, G. Perriello, et al. · American Journal of Physiology-Endocrinology and Metabolism · 136
Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man.
1988 · P De Feo, V Gallai, et al. · Journal of Clinical Investigation · 136
PDF
Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM
1994 · E. Torlone, C. Fanelli, et al. · Diabetologia · 127
PDF
A Reliable and Reproducible Test for Adequate Glucose Counterregulation in Type I Diabetes Mellitus
1984 · G B Bolli, P De Feo, et al. · Diabetes · 121
Association of MHC Class I chain-related A (MIC-A) gene polymorphism with Type I diabetes
2000 · G. Gambelunghe, M. Ghaderi, et al. · Diabetologia · 117
PDF
21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease
1997 · A FALORNI, S LAURETI, et al. · Clinical & Experimental Immunology · 117
Demonstration of a role for growth hormone in glucose counterregulation
1989 · P. De Feo, G. Perriello, et al. · American Journal of Physiology-Endocrinology and Metabolism · 116
ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with Type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension
1991 · E. Torlone, A. M. Rambotti, et al. · Diabetologia · 114
PDF
Standard Technical Procedures for Microencapsulation of Human Islets for Graft into Nonimmunosuppressed Patients With Type 1 Diabetes Mellitus
2006 · R. Calafiore, G. Basta, et al. · Transplantation Proceedings · 109
X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients
1996 · S Laureti, G Casucci, et al. · The Journal of Clinical Endocrinology & Metabolism · 102
Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime.
1999 · M Ciofetta, C Lalli, et al. · Diabetes Care · 96
Use of the short-acting insulin analogue lispro in intensive treatment of Type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal
1998 · P. Del Sindaco, M. Ciofetta, et al. · Diabetic Medicine · 91
Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in Type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning
1990 · G. Perriello, P. De Feo, et al. · Diabetologia · 90
PDF
The dawn phenomenon in Type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity
1991 · G. Perriello, P. De Feo, et al. · Diabetologia · 84
PDF
Works count: 197
Citation count: 6,003
H-index: 39
I10-index: 78
Year
Topic
Type